Eastridge B J, Mabry R L, Seguin P, et al. Death on the battlefield (2001-2011): implications for the future of combat casualty care[J]. J Trauma Acute Care, 2012, 73(6 Suppl 5):S431.
Frank K B, John B H, Martin A S, et al. Fluid resuscitation for hemorrhagic shock in tactical combat casualty care: tccc guidelines change 14-01 - 2 June 2014[J]. J Spec Oper Med, 2014, 14(3):13-38.
[6]
Jabaley C,Dudaryk R. Fluid resuscitation for trauma patients: crystalloids versus colloids[J]. Curr Anesthesiol Rep, 2014, 4(3):216-224.
[7]
Schreiber M A. The use of normal saline for resuscitation in trauma[J]. J Trauma,2011, 70(5 Suppl):S13-4.
[8]
Tran A, Yates J, Lau A, et al. Permissive hypotension vs. conventional resuscitation strategies in adult trauma patients with hemorrhagic shock: a systematic review and meta-analysis of randomized controlled trials[J]. J Trauma Acute Care Surg, 2018, 84(5):802-808.
[9]
Barker M E. 0.9% saline induced hyperchloremic acidosis.[J]. J Trauma Nurs,2015,22(2) :111-116.
[10]
Lobo D N, Awad S. Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent ‘pre-renal’ acute kidney injury? [J]. Kidney Int, 2014, 86(6):1096-1105.
[11]
Ying W, Wei G, Dawei G, et al. Effects of plasma lyte lactated ringers and normal saline on acid base status and intestine injury in the initial treatment of hemorrhagic shock[J]. Am J Emerg Med, 2016, 35(2):317-321.
[12]
Nicholas M, Studer M D,April F B, et al. Albumin for prehospital fluid resuscitation of hemorrhagic shock in tactical combat casualty care[J]. J Spec Oper Med, 2016, 17(2):82-88.
[13]
Pablo P, Ian R. Colloids versus crystalloids for fluid resuscitation in critically ill patients[J]. Cochrane Database Syst Rev, 2011, 3(3):CD000567.
[14]
Ryan M L, Ogilvie M P, Pereira B M, et al. Effect of hetastarch bolus in trauma patients requiring emergency surgery[J]. J Spec Oper Med, 2012, 12(3):57-67.
[15]
Ogilvie M P, Ryan M L, Proctor K G. Hetastarch during initial resuscitation from trauma[J]. J Trauma Acute Care Surg, 2011,70(5 Suppl):S19-S21.
[16]
Safety C. Boxed warning on increased mortality and severe renal injury, and additional warning on risk of bleeding, for use of hydroxyethyl starch solutions in some settings[OB/OL]. http://www.fda.gov/biologicsbloodvaccines/safetyavailability/ucm35827.htm.
[17]
Nicolas J P, Andrew D M, Nichole K I, et al. ROTEM significantly optimizes transfusion practices for damage control resuscitation in combat casualties[J]. J Trauma Acute Care Surg, 2017, 83(3):373-380.
[18]
Yann D, Anne S, Thomas P, et al. Whole blood transfusion closest to the point-of-injury during french remote military operations[J]. J Trauma Acute Care Surg, 2017, 82(6):1.
[19]
Spinella P C. Warm fresh whole blood transfusion for severe hemorrhage: U S. Military and potential civilian applications[J]. Crit Care Med, 2008, 36(7 Suppl):S340-S355.
[20]
Butler F K. TCCC Updates: two decades of saving lives on the battlefield: tactical combat casualty care turns 20[J]. J Spec Oper Med, 2016, 17(2):166-172.
[21]
Andrew D F, Brandon M C, Jason B C, et al. Conducting fresh whole blood transfusion training[J]. J Trauma Acute Care Surg, 2019, 87(1S Suppl 1):10.
[22]
Glassberg E, Nadler R, Rasmussen T E, et al. Point of injury use of reconstituted freeze dried plasma as a resuscitative fluid[J]. J Trauma Acute Care Surg, 2013, 75(2 Suppl2):S111-S114.
[23]
Schoenfeld H, Pruss A, Keller M, et al. Lyophilised plasma: evaluation of clotting factor activity over 6 days after reconstitution for transfusion[J]. J Clin Pathol, 2010, 63(8):726-730.
Fisher A D,Carius B M,April M D, et al. An analysis of adherence to tactical combat casualty care guidelines for the administration of tranexamic acid[J]. J Emerg Med,2019, 57(5):646-652.
2020, Vol. 31 
